Literature DB >> 13684386

Induced primaquine resistance in vivax malaria.

J ARNOLD, A S ALVING, C B CLAYMAN.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/therapy; MALARIA/therapy; PLASMODIUM VIVAX/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 13684386     DOI: 10.1016/0035-9203(61)90103-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  8 in total

Review 1.  The evolution of tafenoquine--antimalarial for a new millennium?

Authors:  W Peters
Journal:  J R Soc Med       Date:  1999-07       Impact factor: 5.344

Review 2.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

Review 3.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

Review 4.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

5.  New tissue schizontocidal antimalarial drugs.

Authors:  D E Davidson; A L Ager; J L Brown; F E Chapple; R E Whitmire; R N Rossan
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

Review 6.  Determinants of relapse periodicity in Plasmodium vivax malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2011-10-11       Impact factor: 2.979

7.  Imported tertian malaria resistant to primaquine.

Authors:  D J Na; J D Han; D Y Cha; I K Song; H W Choi; E A Chung; C W Park; J S Choi
Journal:  Korean J Intern Med       Date:  1999-07       Impact factor: 2.884

Review 8.  Anti-malarial drug effects on parasite dynamics in vivax malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2021-03-21       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.